Across TCGA pan-cancer cohorts, CFAP126 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated CFAP126 data layer compared with 1 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CFAP126 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP126 expression acts as an unfavorable survival marker.

LUAD, LSCC, and UCEC are the cancer types where CFAP126 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.821	0.998	.001	53	view →
LSCC	OS	Median	All	0.708	0.965	.029	3	view →
UCEC	OS	Median	All	0.798	1.000	.024	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: CFAP126 tumor-vs-normal RNA expression · all CFAP126 data types